On the other hand, the synergistic interaction of MCT4 and GPC3 was suggested by increased MCT4 immunoreactivity in HCC that showed increased GPC3 immunoreactivity, and this pattern comprised 11% of the cases (Fig. 2). The gene discussed is GPC3; the disease is hepatocellular carcinoma.